- Investing Ideas
- Chinese Pharmaceuticals & Biotech Sustainable Track Record
Chinese Pharmaceuticals & Biotech Sustainable Track Record
Results
5
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
5 companies
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥48.2b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥51.08
7D
0%
1Y
21.5%
WuXi AppTec
Market Cap: CN¥391.5b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥127.00
7D
4.9%
1Y
56.8%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥15.4b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥42.80
7D
7.8%
1Y
12.1%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥56.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥124.10
7D
2.0%
1Y
25.3%
Xiamen Amoytop Biotech
Market Cap: CN¥23.9b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥60.29
7D
9.9%
1Y
-21.4%